212 related articles for article (PubMed ID: 14759617)
1. The contraceptive vaginal ring, NuvaRing, and antimycotic co-medication.
Verhoeven CH; van den Heuvel MW; Mulders TM; Dieben TO
Contraception; 2004 Feb; 69(2):129-32. PubMed ID: 14759617
[TBL] [Abstract][Full Text] [Related]
2. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
Verhoeven CH; Dieben TO
Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
[TBL] [Abstract][Full Text] [Related]
3. Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.
Simmons KB; Kumar N; Plagianos M; Roberts K; Hoskin E; Han L; Alami M; Creasy G; Variano B; Merkatz R
Contraception; 2018 Mar; 97(3):270-276. PubMed ID: 29097225
[TBL] [Abstract][Full Text] [Related]
4. Complete and robust ovulation inhibition with NuvaRing.
Killick S
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():13-8; discussion 37-9. PubMed ID: 12659397
[TBL] [Abstract][Full Text] [Related]
5. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
Roumen FJ; Dieben TO
Fertil Steril; 2006 Jan; 85(1):57-62. PubMed ID: 16412731
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.
Timmer CJ; Mulders TM
Clin Pharmacokinet; 2000 Sep; 39(3):233-42. PubMed ID: 11020137
[TBL] [Abstract][Full Text] [Related]
7. Vaginal ring contraception.
Kerns J; Darney P
Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive.
van den Heuvel MW; van Bragt AJ; Alnabawy AK; Kaptein MC
Contraception; 2005 Sep; 72(3):168-74. PubMed ID: 16102549
[TBL] [Abstract][Full Text] [Related]
9. The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
Tuppurainen M; Klimscheffskij R; Venhola M; Dieben TO
Contraception; 2004 May; 69(5):389-94. PubMed ID: 15105061
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic bioequivalence, safety and acceptability of Ornibel
Algorta J; Diaz M; de Benito R; Lefebvre M; Sicard E; Furtado M; Regidor PA; Ronchi C
Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):429-438. PubMed ID: 29336615
[TBL] [Abstract][Full Text] [Related]
11. [Vaginal contraception: new form of administration of hormonal contraception].
Knuist M; Hamerlynck JV
Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2095-7. PubMed ID: 14619196
[TBL] [Abstract][Full Text] [Related]
12. The combined contraceptive ring NuvaRing and spermicide co-medication.
Haring T; Mulders TM
Contraception; 2003 Apr; 67(4):271-2. PubMed ID: 12684146
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
[TBL] [Abstract][Full Text] [Related]
14. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
[TBL] [Abstract][Full Text] [Related]
15. [Nuvaring is a novel contraception method].
Dinov I; Batashki I; Ivanov S
Akush Ginekol (Sofiia); 2007; 46 Suppl 2():45-46. PubMed ID: 18217305
[No Abstract] [Full Text] [Related]
16. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.
Roumen F
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():19-24; discussion 37-9. PubMed ID: 12659398
[TBL] [Abstract][Full Text] [Related]
17. Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group.
Brown D; Henzl MR; Kaufman RH
J Reprod Med; 1999 Nov; 44(11):933-8. PubMed ID: 10589403
[TBL] [Abstract][Full Text] [Related]
18. The contraceptive vaginal ring.
Edwardson J; Jamshidi R
Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
[TBL] [Abstract][Full Text] [Related]
19. Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Duijkers I; Klipping C; Heger-Mahn D; Fayad GN; Frenkl TL; Cruz SM; Korver T
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):245-254. PubMed ID: 30203681
[TBL] [Abstract][Full Text] [Related]
20. Lower hormone dosage with improved cycle control.
Vree M
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():25-30; discussion 37-9. PubMed ID: 12659399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
